PŘEHLEDOVÉ ČLÁNKY / REVIEW ARTICLES Orální hygiena jako klíčová součást balíčku péče v prevenci ventilátorové pneumonie: shrnutí a kritická analýza doporučených postupů v r. 2023 46 | ANESTEZIOLOGIE A INTENZIVNÍ MEDICÍNA / Anest intenziv Med. 2024;35(1):42-46 / www.aimjournal.cz nonprophylactic systemic antibiotic use in patients undergoing heart surgery. Chest. 1996 Jun;109(6):1556-61. doi: 10.1378/chest.109. 6. 1556. PMID: 8769511. 34. Houston S, Hougland P, Anderson JJ, LaRocco M, Kennedy V, Gentry LO. Effectiveness of 0.12% chlorhexidine gluconate oral rinse in reducing prevalence of nosocomial pneumonia in patients undergoing heart surgery. Am J Crit Care. 2002 Nov;11(6):567-70. PMID: 12425407. 35. Segers P, Speekenbrink RG, Ubbink DT, van Ogtrop ML, de Mol BA. Prevention of nosocomial infection in cardiac surgery by decontamination of the nasopharynx and oropharynx with chlorhexidine gluconate: a randomized controlled trial. JAMA. 2006 Nov 22;296(20):2460-6. doi: 10.1001/jama.296. 20. 2460. PMID: 17119142. 36. Chye RML, Perrotti V, Piattelli A, Iaculli F, Quaranta A. Effectiveness of Different Commercial Chlorhexidine‑Based Mouthwashes After Periodontal and Implant Surgery: A Systematic Review. Implant Dent. 2019 Feb;28(1):74-85. doi: 10.1097/ID.0000000000000854. PMID: 30648980. 37. Solderer A, Kaufmann M, Hofer D, Wiedemeier D, Attin T, Schmidlin PR. Efficacy of chlorhexidine rinses after periodontal or implant surgery: a systematic review. Clin Oral Investig. 2019 Jan;23(1):21-32. doi: 10.1007/s00784-018-2761-y. Epub 2018 Dec 7. PMID: 30535817. 38. Brookes ZLS, Bescos R, Belfield LA, Ali K, Roberts A. Current uses of chlorhexidine for management of oral disease: a narrative review. J Dent. 2020 Dec;103:103497. doi: 10.1016/j. jdent.2020.103497. Epub 2020 Oct 17. PMID: 33075450; PMCID: PMC7567658. 39. Karpiński TM, Szkaradkiewicz AK. Chlorhexidine‑pharmaco‑biological activity and application. Eur Rev Med Pharmacol Sci. 2015 Apr;19(7):1321-6. PMID: 25912596. 40. Dehghani Nazhvani A, Haddadi P, Badiee P, Malekhoseini SA, Jafarian H. Antifungal Effects of Common Mouthwashes on Candida Strains Colonized in the Oral Cavities of Liver Transplant Recipients in South Iran in 2014. Hepat Mon. 2016 Jan 30;16(1):e31245. doi: 10.5812/hepatmon.31245. PMID: 27110254; PMCID: PMC4834379. 41. Ann A, Easton Ch, Liddle L, Hickson M, Moore M, Bescos R. The effects of antibacterial mouthwash on the oral microbiome: potential consequences for intensive care patients. Clinical Nutrition ESPEN (2018). p. 255-256, https://doi.org/10.1016/j.clnesp.2018. 12. 022. 42. de Soet JJ, Nyvad B, Kilian M. Strain‑related acid production by oral streptococci. Caries Res. 2000 Nov‑Dec;34(6):486-90. doi: 10.1159/000016628. PMID: 11093023. 43. Brooks GA. The Science and Translation of Lactate Shuttle Theory. Cell Metab. 2018 Apr 3;27(4):757-785. doi: 10.1016/j.cmet.2018. 03. 008. PMID: 29617642. 44. Bescos R, Ashworth A, Cutler C, Brookes ZL, Belfield L, Rodiles A, et al. Effects of Chlorhexidine mouthwash on the oral microbiome. Sci Rep. 2020 Mar 24;10(1):5254. doi: 10.1038/s41598-020-61912-4. PMID: 32210245; PMCID: PMC7093448. 45. Gunsolley JC. Clinical efficacy of antimicrobial mouthrinses. J Dent. 2010 Jun;38 Suppl 1:S6-10. doi: 10.1016/S0300-5712(10)70004-X. PMID: 20621242. 46. Desai C. Meyler’s side effects of drugs. In: Aronson JK. The international encyclopedia of adverse drug reactions and interactions. 16th ed. Indian J Pharmacol. 2016. PMCID: PMC4825447. p. 239-248. 47. Plantinga NL, Wittekamp BHJ, Leleu K, Depuydt P, Van den Abeele AM, Brun‑Buisson C, et.al. Oral mucosal adverse events with chlorhexidine 2% mouthwash in ICU. Intensive Care Med. 2016 Apr;42(4):620-621. doi: 10.1007/s00134-016-4217-7. Epub 2016 Feb 5. PMID: 26850333; PMCID: PMC5413521. 48. Cieplik F, Deng D, Crielaard W, Buchalla W, Hellwig E, Al‑Ahmad A, et al. Antimicrobial photodynamic therapy - what we know and what we don’t. Crit Rev Microbiol. 2018 Sep;44(5):571-589. doi: 10.1080/1040841X.2018.1467876. Epub 2018 May 11. PMID: 29749263. 49. Tartaglia GM, Tadakamadla SK, Connelly ST, Sforza C, Martín C. Adverse events associated with home use of mouthrinses: a systematic review. Ther Adv Drug Saf. 2019 Sep 23;10:2042098619854881. doi: 10.1177/2042098619854881. PMID: 31579502; PMCID: PMC6759706. 50. Pemberton MN, Gibson J. Chlorhexidine and hypersensitivity reactions in dentistry. Br Dent J. 2012 Dec;213(11):547-50. doi: 10.1038/sj.bdj.2012.1086. PMID: 23222325. 51. Xue Y, Zhang S, Yang Y, Lu M, Wang Y, Zhang T, et al. Acute pulmonary toxic effects of chlorhexidine (CHX) following an intratracheal instillation in rats. Hum Exp Toxicol. 2011 Nov;30(11):1795-803. doi: 10.1177/0960327111400104. Epub 2011 Feb 21. PMID: 21339254. 52. Balloni S, Locci P, Lumare A, Marinucci L. Cytotoxicity of three commercial mouthrinses on extracellular matrix metabolism and human gingival cell behaviour. Toxicol In Vitro. 2016 Aug;34:88-96. doi: 10.1016/j.tiv.2016. 03. 015. Epub 2016 Mar 31. PMID: 27039991. 53. Faria G, Cardoso CR, Larson RE, Silva JS, Rossi MA. Chlorhexidine‑induced apoptosis or necrosis in L929 fibroblasts: A role for endoplasmic reticulum stress. Toxicol Appl Pharmacol. 2009 Jan 15;234(2):256-65. doi: 10.1016/j.taap.2008. 10. 012. Epub 2008 Nov 6. PMID: 19027770. 54. Carlin V, Matsumoto MA, Saraiva PP, Artioli A, Oshima CT, Ribeiro DA. Cytogenetic damage induced by mouthrinses formulations in vivo and in vitro. Clin Oral Investig. 2012 Jun;16(3):813-20. doi: 10.1007/s00784-011-0559-2. Epub 2011 May 6. PMID: 21547372. 55. Ros‑Llor I, Lopez‑Jornet P. Cytogenetic analysis of oral mucosa cells, induced by chlorhexidine, essential oils in ethanolic solution and triclosan mouthwashes. Environ Res. 2014 Jul;132:140-5. doi: 10.1016/j.envres.2014. 03. 032. Epub 2014 Apr 25. PMID: 24769563. 56. Klompas M, Speck K, Howell MD, Greene LR, Berenholtz SM. Reappraisal of routine oral care with chlorhexidine gluconate for patients receiving mechanical ventilation: systematic review and meta‑analysis. JAMA Intern Med. 2014 May;174(5):751-61. doi: 10.1001/ jamainternmed.2014.359. PMID: 24663255. 57. Klompas M, Li L, Kleinman K, Szumita PM, Massaro AF. Associations Between Ventilator Bundle Components and Outcomes. JAMA Intern Med. 2016 Sep 1;176(9):1277-83. doi: 10.1001/jamainternmed.2016.2427. PMID: 27428482. 58. Price R, MacLennan G, Glen J; SuDDICU Collaboration. Selective digestive or oropharyngeal decontamination and topical oropharyngeal chlorhexidine for prevention of death in general intensive care: systematic review and network meta‑analysis. BMJ. 2014 Mar 31;348:g2197. doi: 10.1136/bmj.g2197. PMID: 24687313; PMCID: PMC3970764. 59. Hirata K, Kurokawa A. Chlorhexidine gluconate ingestion resulting in fatal respiratory distress syndrome. Vet Hum Toxicol. 2002 Apr;44(2):89-91. PMID: 11931511. 60. Blot SI, Poelaert J, Kollef M. How to avoid microaspiration? A key element for the prevention of ventilator‑associated pneumonia in intubated ICU patients. BMC Infect, DiS. 2014 Nov 28;14:119. doi: 10.1186/1471-2334-14-119. PMID: 25430629; PMCID: PMC4289393. 61. Blot S. Antiseptic mouthwash, the nitrate‑nitrite‑nitric oxide pathway, and hospital mortality: a hypothesis generating review. Intensive Care Med. 2021 Jan;47(1):28-38. doi: 10.1007/s00134-020-06276-z. Epub 2020 Oct 16. PMID: 33067640; PMCID: PMC7567004. 62. Shiva S, Huang Z, Grubina R, Sun J, Ringwood LA, MacArthur PH, et al. Deoxymyoglobin is a nitrite reductase that generates nitric oxide and regulates mitochondrial respiration. Circ Res. 2007 Mar 16;100(5):654-61. doi: 10.1161/01.RES.0000260171.52224.6 b. Epub 2007 Feb 9. PMID: 17293481. 63. Rassaf T, Lauer T, Heiss C, Balzer J, Mangold S, Leyendecker T, et al. Nitric oxide synthase ‑derived plasma nitrite predicts exercise capacity. Br J Sports Med. 2007 Oct;41(10):66973; discussion 673. doi: 10.1136/bjsm.2007.035758. Epub 2007 May 11. PMID: 17496072; PMCID: PMC2465183. 64. Millar TM, Stevens CR, Benjamin N, Eisenthal R, Harrison R, Blake Dr. Xanthine oxidoreductase catalyses the reduction of nitrates and nitrite to nitric oxide under hypoxic conditions. FEBS Lett. 1998 May 8;427(2):225-8. doi: 10.1016/s0014-5793(98)00430-x. PMID: 9607316. 65. Kapil V, Haydar SM, Pearl V, Lundberg JO, Weitzberg E, Ahluwalia A. Physiological role for nitrate‑reducing oral bacteria in blood pressure control. Free Radic Biol Med. 2013 Feb;55:93-100. doi: 10.1016/j.freeradbiomed.2012. 11. 013. Epub 2012 Nov 23. PMID: 23183324; PMCID: PMC3605573. 66. Bondonno CP, Liu AH, Croft KD, Considine MJ, Puddey IB, Woodman RJ, et al. Antibacterial mouthwash blunts oral nitrate reduction and increases blood pressure in treated hypertensive men and women. Am J Hypertens. 2015 May;28(5):572-5. doi: 10.1093/ajh/ hpu192. Epub 2014 Oct 30. PMID: 25359409. 67. Torres A, Niederman MS, Chastre J, Ewig S, Fernandez‑Vandellos P, Hanberger H, at al. International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital ‑acquired pneumonia and ventilator‑associated pneumonia: Guidelines for the management of hospital‑acquired pneumonia (HAP)/ventilator‑associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociación Latinoamericana del Tórax (ALAT). Eur Respir J. 2017 Sep 10;50(3):1700582. doi: 10.1183/13993003.00582-2017. PMID: 28890434. 68. Dale CM, Rose L, Carbone S, Pinto R, Smith OM, Burry L, et al. Effect of oral chlorhexidine de‑adoption and implementation of an oral care bundle on mortality for mechanically ventilated patients in the intensive care unit (CHORAL): a multi‑center stepped wedge cluster‑randomized controlled trial. Intensive Care Med. 2021 Nov;47(11):1295-1302. doi: 10.1007/s00134-021-06475-2. Epub 2021 Oct 5. PMID: 34609548; PMCID: PMC8490143.
RkJQdWJsaXNoZXIy NDA4Mjc=